1. Home
  2. CREX vs MCRB Comparison

CREX vs MCRB Comparison

Compare CREX & MCRB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Creative Realities Inc.

CREX

Creative Realities Inc.

HOLD

Current Price

$2.61

Market Cap

35.7M

Sector

Technology

ML Signal

HOLD

Logo Seres Therapeutics Inc.

MCRB

Seres Therapeutics Inc.

N/A

Current Price

$4.06

Market Cap

41.2M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
CREX
MCRB
Founded
N/A
2010
Country
United States
United States
Employees
N/A
66
Industry
EDP Services
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
35.7M
41.2M
IPO Year
2015
2015

Fundamental Metrics

Financial Performance
Metric
CREX
MCRB
Price
$2.61
$4.06
Analyst Decision
Buy
Analyst Count
0
2
Target Price
N/A
$14.00
AVG Volume (30 Days)
25.4K
47.4K
Earning Date
04-14-2026
05-11-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$18,437,000.00
$789,000.00
Revenue This Year
$81.98
N/A
Revenue Next Year
$14.82
N/A
P/E Ratio
N/A
N/A
Revenue Growth
5.61
N/A
52 Week Low
$2.22
$3.90
52 Week High
$4.42
$29.98

Technical Indicators

Market Signals
Indicator
CREX
MCRB
Relative Strength Index (RSI) 39.64 34.20
Support Level N/A N/A
Resistance Level $3.74 $5.80
Average True Range (ATR) 0.21 0.34
MACD 0.00 -0.11
Stochastic Oscillator 7.81 7.80

Price Performance

Historical Comparison
CREX
MCRB

About CREX Creative Realities Inc.

Creative Realities Inc, along with its subsidiaries, is engaged in providing digital marketing technology & solutions to world-wide retail companies, luxury and other individual retail brands, advertising networks, outdoor clients, enterprises, and other organizations. The company operates in one reportable segment, marketing technology solutions. It offers solutions related to digital merchandising systems, omnichannel customer engagement systems, interactive digital shopping assistants, advisors and kiosks, and high-end audio-visual networks, along with marketing technologies such as mobile, social media, point-of-sale transactions, beaconing, and web-based media. Geographically, the company generates maximum revenue from the United States, and the rest from Canada.

About MCRB Seres Therapeutics Inc.

Seres Therapeutics Inc is a clinical-stage biotechnology company focused on the development of live biotherapeutic candidates. Its pipeline includes candidates such as SER-155 and SER-603, aimed at preventing and treating bacterial infections, antimicrobial resistance, and gastrointestinal immune diseases. The company operates as a single reportable segment, mainly developing microbiome-based therapies targeting bacterial infections, antimicrobial resistance, and gastrointestinal immune diseases.

Share on Social Networks: